Pag-aaral pangklinika para sa Cirrhosis sa New York
6 pag-aaral para sa Cirrhosis ang naghahanap ng mga kalahok sa mga site sa New York.
Mga Lungsod sa New York
Opisyal na teksto ng pag-aaral (English)
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Columbia University Medical Center, New York
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07325526Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- New York Presbyterian/Weill Cornell, New York
- Columbia University Iriving School of Medicine, New York
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05832229National Liver Cancer Screening Trial
- The Feinstein Institutes, Northwell Health, Inc., Manhasset
Nagre-recruitPhase 4
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06084234LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn
- Basil Clinical, Laurelton
- Icahn School of Medicine at Mount Sinai, New York
- at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06632444A Study of SIPLIZUMAB in AILD and LT Patients
- Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 24, 2025 · NCT06455280Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Weill Cornell Medicine, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore Medical Center, New York
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 20, 2025 · NCT04613921Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.